Journal profile · Oncology
European Journal of Cancer Prevention
ISSN 0959-8278 · eISSN 1473-5709 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1991
European Journal of Cancer Prevention: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.45; JCR Q3 (journal website); hybrid open access; median 70 days to acceptance (47 articles, last 24 months); community-reported acceptance: about 50%; 56 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Cancer Prevention is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Colorectal Cancer Screening and Detection and Cancer Risks and Factors, together about 33.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Explore European Journal of Cancer Prevention, featuring peer‑reviewed articles, clinical studies, and the latest medical research.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Giovanni CorsoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine13%
- Colorectal Cancer Screening and DetectionMedicine12.3%
- Cancer Risks and FactorsMedicine8.3%
- Gastric Cancer Management and OutcomesMedicine6.3%
- Nutritional Studies and DietMedicine6.1%
- Helicobacter pylori-related gastroenterology studiesMedicine5.7%
- Genetic factors in colorectal cancerMedicine5.6%
- Cervical Cancer and HPV ResearchMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · ONCOLOGY · rank 204/333
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.45LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 73LetPub ·
- h-index
- 103OpenAlex ·
- i10-index
- 1,766OpenAlex ·
- 2-year mean citedness
- 2.68OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 20.41%LetPub ·
Volume
- Articles per year
- 63LetPub ·
Articles by year OpenAlex count · 3,406 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 15 | 7 |
| 2025 | 56 | 15 | 112 |
| 2024 | 79 | 28 | 339 |
| 2023 | 95 | 24 | 719 |
| 2022 | 44 | 12 | 381 |
| 2021 | 102 | 27 | 787 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
70 daysMedian, submission to acceptance · P25–P75 51 days – 96 days
- Acceptance to online
- median 33 days (47 articles)
- Submission to online
- median 107 days
- Sample
- 47 articles with submission and acceptance dates (117 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1991
- ISSN
- 0959-8278
- Electronic ISSN
- 1473-5709
- Latest issue on the website
- Volume 35, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Cancer Prevention
What CAS zone is European Journal of Cancer Prevention in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Cancer Prevention is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Cancer Prevention?
The latest impact factor listed by LetPub is 2.45; CiteScore 4.7, h-index 103.
How long does peer review take at European Journal of Cancer Prevention?
Based on the dates recorded on 47 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 70 days (interquartile range 51–96 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is European Journal of Cancer Prevention in?
The journal's website gives JCR Q3; by category, ONCOLOGY Q3 (204/333). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index European Journal of Cancer Prevention?
According to LetPub and DOAJ records, European Journal of Cancer Prevention is indexed in SCIE and Scopus.
Is European Journal of Cancer Prevention open access, and what is the APC?
European Journal of Cancer Prevention is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .